In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Structure

CRT Nucleus: Comprises the CRT chairs and representatives from the ESC and industry. The nucleus is responsible for driving and supervising CRT activities. 

CRT Plenary Group: Comprises all CRT members.

 CRT Plenary Group is composed of: 

  • ESC Board Members 
  • Industry representatives from the cardiovascular field who paid a membership fee to join (2 representatives per company).

CRT Governance

The administration of the CRT is conducted by a group composed of Co-Chairs and Nucleus Members

CRT Co-Chairs: Job description 

The CRT is co-chaired by an ESC and an industry representative: 

  • For the ESC, this is the President-Elect (2-year mandate)
  • For industry, an election by the CRT Industry members for a 3-year mandate.
CRT Nucleus Members: Job description 

This group oversees the CRT activities and is composed of:

  • CRT Co-Chairs
  • ESC Members appointed by the ESC Co-Chair (2-year mandate)
  • The previous Industry Chair as Advisor
  • 7 elected industry representatives from each industry sector (2-year mandate aligned with the ESC mandate); elected by the industry members

CRT Academic Members, mandate September 2024-August 2026

CRT Industry Members, mandate 2024-2026

Industry Co-Chair position

Since 2018, an election process has been established to appoint the Industry Co-Chair of the ESC Cardiovascular Round Table (CRT).

Professor Alexandra Goncalves was elected in 2022 for a three-year term that runs until August 2025.

Election Results:

We are pleased to announce, Dr. Bettina Kraus: Boehringer Ingelheim Pharmaceuticals Inc. has been elected and will start her mandate in September 2025 until August 2028